No Detail Found!

Interferon Response in Epithelial Cell Models COVID-19: Evidence from Airway

Author(s)
Muneef M. Aldhafeeri Department of Clinical Laboratories Sciences, College of Applied Medical Sciences, University of Hafr Al-Batin, Hafr Al-Batin 39524, Saudi Arabia
Abstract
The Coronavirus Disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has posed significant challenges in understanding host antiviral immune responses. Among these, interferons (IFNs) play a critical role as the first line of defence against viral infections. IFNs are classified into three major types: type I, type II and type III, each contributing to antiviral immunity by activating interferon-stimulated genes that inhibit viral replication. This review aims to summarise current evidence regarding the role of interferons in SARSCoV-2 infection, with a particular focus on airway epithelial cell models. These models are especially valuable as they closely mimic the structural and functional characteristics of the human respiratory epithelium, including the expression of Angiotensin-Converting Enzyme 2 (ACE2) receptors, thereby providing a physiologically relevant platform for studying viral entry, replication and host immune responses. A comprehensive literature search was conducted on 15 July 2025 using databases and keywords including “airway epithelial cells,” “SARS-CoV-2,” “COVID-19,” and “interferon.” A total of 86 articles were identified, of which 50 were included based on predefined relevance criteria, including studies focusing on interferon responses in airway epithelial models, experimental or clinical relevance to SARS-CoV-2 infection and availability of full-text articles in English. The findings indicate that interferon responses vary depending on cell type, viral variants and host factors such as age and environmental exposure. In conclusion, interferons play a pivotal role in the pathogenesis and potential treatment of COVID-19. Airway epithelial cell models remain essential tools for elucidating these mechanisms and for developing targeted antiviral therapies.
Publication Details
Page(s) 103-109
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: s1, Year: 2026

Request the full text from PASTIC

Keywords
COVID-19, SARS-CoV-2, IFN, Immunology, Covid-19, Cell Cutlure, Epthileial
References
Wang Y. .2023 .Combating pan-coronavirus infection by indomethacin through simultaneously inhibiting viral replication and inflammatory response. ” iScience, 107631(2023) : 107631.
Du S. .2025 .Airway basal stem cells inflammatory alterations in COVID-19 and mitigation by mesenchymal stem cells. ” Cell Proliferation, : .
Broadbent L. .2022 .An endogenously activated antiviral state restricts SARS-CoV-2 infection in differentiated primary airway epithelial cells. PLoS One, 0266412(4) : .
Chen Q. .2022 .ACE2 expression in organotypic human airway epithelial cultures and airway biopsies. , 813087 : 813087.
Ziegler C.G.K. .2020 .SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells. ” Cell, 04(2020) : 1016-1035.
Wang X. .2025 .Single-cell transcriptomics reveals a compartmentalized antiviral interferon response in the nasal epithelium of mice. ” Journal of Virology, 99(3) : 24-24.
Nchioua R. .2023 .Reduced replication but increased interferon resistance of SARS-CoV-. Omicron BA.1.” Life Science Alliance, 6(6) : .
Zaleska A. .2024 .IFN lambda deficiency contributes to severe COVID-19 outcomes. International Journal of Molecular Sciences, 25(19) : 10719.
Subramaniyan B. . .Anti-SARS-CoV-2 small molecule targeting of oxysterol-binding protein activates antiviral innate immunity. ” ACS Infectious Diseases, 11(2025) : 1064-1077.
Vanderwall E.R. . .Airway epithelial interferon response to SARS-CoV-2 Is inferior to rhinovirus and heterologous rhinovirus infection suppresses SARS-CoV-2 replication. Scientific Reports, 12(2022) : 6972.
Assou S. .2023 .Transcriptome landscape of the in vitro human airway epithelium response to SARS-CoV-2. International Journal of Molecular Sciences, 24(15) : 12177.
Rajan A. .2022 .The human nose organoid respiratory virus model. ” mBio, 13(1) : 21-21.
Shi G. . .Omicron spike confers enhanced infectivity and interferon resistance. ” Nature Communications, 15(2024) : 889.
Castaneda D.C. .2023 .Spatiotemporally organized immunomodulatory response to SARS-CoV-2. , 107374(2023) : 107374.
Gamage A.M. .2022 .Human nasal epithelial cells sustain persistent SARS-CoV-2 infection. , 13(1) : 21-21.
Rebendenne A. .2021 .SARS-CoV-2 triggers an MDA-5- dependent interferon response. ” Journal of Virology, 95(8) : 20-20.
Vanderheiden A. .2020 .Type I and III interferons restrict SARS-CoV-2 Infection.. Journal of Virology, 94(19) : 20-20.
Mulay A. .2021 .SARS-CoV-2 infection of primary human lung epithelium. Cell Reports, 109055(2021) : 109055.
Loo S.L. .2020 .Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses. American Journal of Physiology-Lung Cellular and Molecular Physiology, 319(2020) : L926-L931.
Robinot R. . .SARS-CoV-2 infection induces dedifferentiation of multiciliated cells. ” Nature Communications, 12(2021) : 4354.
Fiege J.K. .2021 .Single-cell resolution of SARS-CoV-2 tropism, antiviral responses and susceptibility to therapies in primary human airway epithelium. PLoS Pathogens, 1009292(1) : .
Wang R. .2021 .Human airway lineages derived from pluripotent stem cells reveal epithelial responses to SARSCoV-2 Infection. American Journal of Physiology-Lung Cellular and Molecular Physiology, 322(2022) : L462-L478.
Banerjee A. .2021 .Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses. ” iScience, 102477(2021) : 102477.
Lokugamage K.G. .2020 .Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. ” Journal of Virology, 94(23) : 20-20.
Bordoni V. .2022 .SARS-CoV-2 infection of airway epithelium triggers endothelial activation and senescence. ” Cells, 11(18) : 2877.
Mhlekude B. .2023 .Pharmacological inhibition of BET proteins induces an NRF2-mediated antiviral state. PLoS Pathogens, 1011657(9) : .
Finney LJ .2020 .Inhaled corticosteroids downregulate ACE2 in COPD via interferon suppression. ” Journal of Allergy and Clinical Immunology, 09(2021) : 510-519.
Schuhenn J. .2022 .Differential interferon-α Subtype Signatures Suppress SARS-CoV-2 Infection.. Proceedings of the National Academy of Sciences, 119(8) : .
Hatton C.F. . .Delayed induction of type I and III interferons mediates nasal epithelial permissiveness to SARSCoV-2. , 12(2021) : 7092.
Sposito B. .2021 .Interferon landscape along the respiratory tract impacts COVID-19 severity. Cell, 08(19) : 4953-4968.
Zhu Q. .2021 .Inhibition of coronavirus infection by a synthetic STING agonist. Antiviral Research, 105015 : 105015.
Broeckel R. . .STING agonist-induced innate immune responses against respiratory viruses. ” ACS Infectious Diseases, 10(2024) : 3392-3407.
Dagher R. . .Human iPSC-based COPD model to investigate SARS-CoV-2 outcomes. Stem Cells, 42(2024) : 230-250.
Wang Y,SARS-CoV- Y,-Infected Airway Epithelial Cultures Lack Interferon Responses Y .2024 .. ” Clinical and Translational Immunology, 13(4) : 1503.
Wyler E. .2021 .Transcriptomic profiling identifies HSP90 as a COVID-19 therapy target. ” iScience, 102151(2021) : 102151.
Yin X. .2020 .MDA5 governs innate immune response to SARS-CoV-2. Cell Reports, 108628(2021) : 108628.
Ravindra NG .2021 .Single-cell longitudinal analysis of SARS-CoV-2 infection in airway epithelium. PLoS Biology, 3001143(3) : .
Lieberman N.A.P. .2020 .In vivo antiviral host transcriptional response to SARS-CoV-2. PLoS Biology, 3000849(9) : .
Fage C. . .Influenza A(H1N1)pdm09 but Not RSV interferes with SARS-CoV-2 replication. Viruses, 14(2022) : 277.
Cheemarla N.R. . .Viral interference during influenza ASARS-CoV-2 coinfection. Journal of Infectious Diseases, 229(2024) : 1430-1434.
Essaidi-Laziosi M. .2022 .Sequential infections modulate SARSCoV-2 replication. Emerging Microbes & Infections, 2032375(2022) : 412-423.
Blume C . .Novel ACE2 Isoform in Respiratory Epithelia. Nature Genetics, 53(2021) : 205-214.
Radzikowska U,Rhinovirus-Induced Epithelial Inflammasome Suppresses Antiviral Immunity U . .. Nature Communications, 14(2023) : 2329.
Cheemarla N.R. .2021 .Dynamic innate immune response determines SARS-CoV-2 susceptibility. Journal of Experimental Medicine, 218(8) : .
Chen R. . .SARS-CoV-2 infection aggravates cigarette smoke-exposed airway damage. Virology Journal, 20(2023) : 65.
Brocke S.A. .2021 .Woodsmoke exposure alters antiviral response to SARS-CoV-2. American Journal of Physiology-Lung Cellular and Molecular Physiology, 322(2022) : L479-L494.
Purkayastha A. .2020 .SARS-CoV-2 and cigarette smoke increase infection severity. ” Cell Stem Cell, 11(2020) : 869-875.
'Kovski V,P. V .2021 .Temperature-dependent virus-host dynamics for SARS-CoV-2. PLoS Biology, 3001158(3) : .
Otter C.J. .2023 .Interferon signaling in nasal epithelium distinguishes respiratory viruses. , : .
Herder V. .2021 .Elevated temperature inhibits SARS-CoV-2 Replication. PLoS Biology, 3001065(12) : .
0

Citations

0

Downloads

16

Views